7309311000001105: Tomudex 2mg powder for solution for injection vials (AstraZeneca) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Tomudex 2mg powder for solution for injection vials (AstraZeneca)
\UK product\Virtual medicinal product\Product containing precisely raltitrexed 2 milligram/1 vial powder for conventional release solution for injection\Tomudex 2mg powder for solution for injection vials (AstraZeneca)
\UK product\Virtual therapeutic moiety\Raltitrexed\Product containing only raltitrexed in parenteral dose form (medicinal product form)\Product containing precisely raltitrexed 2 milligram/1 vial powder for conventional release solution for injection\Tomudex 2mg powder for solution for injection vials (AstraZeneca)
\UK product\Virtual therapeutic moiety\Raltitrexed\Product containing precisely raltitrexed 2 milligram/1 vial powder for conventional release solution for injection\Tomudex 2mg powder for solution for injection vials (AstraZeneca)
\UK product\Trade family\Tomudex\Tomudex 2mg powder for solution for injection vials (AstraZeneca)

\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Product containing antifolate\Product containing raltitrexed\Raltitrexed\Product containing only raltitrexed in parenteral dose form (medicinal product form)\Product containing precisely raltitrexed 2 milligram/1 vial powder for conventional release solution for injection\Tomudex 2mg powder for solution for injection vials (AstraZeneca)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Product containing antifolate\Product containing raltitrexed\Raltitrexed\Product containing precisely raltitrexed 2 milligram/1 vial powder for conventional release solution for injection\Tomudex 2mg powder for solution for injection vials (AstraZeneca)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing antimetabolite\Product containing antifolate\Product containing raltitrexed\Product containing raltitrexed in parenteral dose form (medicinal product form)\Product containing only raltitrexed in parenteral dose form (medicinal product form)\Product containing precisely raltitrexed 2 milligram/1 vial powder for conventional release solution for injection\Tomudex 2mg powder for solution for injection vials (AstraZeneca)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing raltitrexed\Raltitrexed\Product containing only raltitrexed in parenteral dose form (medicinal product form)\Product containing precisely raltitrexed 2 milligram/1 vial powder for conventional release solution for injection\Tomudex 2mg powder for solution for injection vials (AstraZeneca)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing raltitrexed\Raltitrexed\Product containing precisely raltitrexed 2 milligram/1 vial powder for conventional release solution for injection\Tomudex 2mg powder for solution for injection vials (AstraZeneca)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Product containing raltitrexed\Product containing raltitrexed in parenteral dose form (medicinal product form)\Product containing only raltitrexed in parenteral dose form (medicinal product form)\Product containing precisely raltitrexed 2 milligram/1 vial powder for conventional release solution for injection\Tomudex 2mg powder for solution for injection vials (AstraZeneca)
\Medicinal product\Product manufactured as parenteral dose form\Product containing raltitrexed in parenteral dose form (medicinal product form)\Product containing only raltitrexed in parenteral dose form (medicinal product form)\Product containing precisely raltitrexed 2 milligram/1 vial powder for conventional release solution for injection\Tomudex 2mg powder for solution for injection vials (AstraZeneca)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

20187101000001117 Tomudex 2mg powder for solution for injection vials (AstraZeneca) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

106100901000001119 Tomudex 2mg powder for solution for infusion vials (Pfizer Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Tomudex 2mg powder for solution for injection vials (AstraZeneca)	Is a	Product containing precisely raltitrexed 2 milligram/1 vial powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Tomudex 2mg powder for solution for injection vials (AstraZeneca)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Tomudex 2mg powder for solution for injection vials (AstraZeneca)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only	true	Inferred relationship	Existential restriction modifier
Tomudex 2mg powder for solution for injection vials (AstraZeneca)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Tomudex 2mg powder for solution for injection vials (AstraZeneca)	Has active ingredient	Raltitrexed	false	Inferred relationship	Existential restriction modifier
Tomudex 2mg powder for solution for injection vials (AstraZeneca)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Tomudex 2mg powder for solution for injection vials (AstraZeneca)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Tomudex 2mg powder for solution for injection vials (AstraZeneca)	Has manufactured dose form	Powder for conventional release solution for injection	false	Inferred relationship	Existential restriction modifier
Tomudex 2mg powder for solution for injection vials (AstraZeneca)	Is a	Tomudex	true	Inferred relationship	Existential restriction modifier
Tomudex 2mg powder for solution for injection vials (AstraZeneca)	Has specific active ingredient	Raltitrexed	true	Inferred relationship	Existential restriction modifier
Tomudex 2mg powder for solution for injection vials (AstraZeneca)	Has dispensed dose form	Powder for infusion solution	false	Inferred relationship	Existential restriction modifier
Tomudex 2mg powder for solution for injection vials (AstraZeneca)	Has manufactured dose form	Injection	false	Inferred relationship	Existential restriction modifier
Tomudex 2mg powder for solution for injection vials (AstraZeneca)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Tomudex 2mg powder for solution for injection vials (AstraZeneca)	Has dispensed dose form	Powder for conventional release solution for infusion	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Tomudex 2mg powder for solution for injection vials (AstraZeneca) 1 vial	Is pack of	False	Tomudex 2mg powder for solution for injection vials (AstraZeneca)	Inferred relationship	Existential restriction modifier
Tomudex 2mg powder for solution for injection vials (AstraZeneca) 1 vial	Has AMP	True	Tomudex 2mg powder for solution for injection vials (AstraZeneca)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
20187101000001117	Tomudex 2mg powder for solution for injection vials (AstraZeneca) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
106100901000001119	Tomudex 2mg powder for solution for infusion vials (Pfizer Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module